Prime Medicine Ownership 2024 | Who Owns Prime Medicine Now?
Institutional Ownership
100.00%
Insider Ownership
26.27%
Retail Ownership
-26.27%
Institutional Holders
73.00
Prime Medicine Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ALPHABET INC. | 39.20% | 9.06% | 13,284,688 | - | - | 163,401,662,000 | Mar 31, 2023 |
FMR LLC | 25.13% | 0.01% | 8,517,129 | 54,083 | 0.64% | 104,760,687,000 | Mar 31, 2023 |
REDMILE GROUP, LLC | 5.88% | 1.06% | 1,992,843 | -216,507 | -9.80% | 24,511,969,000 | Mar 31, 2023 |
ARK INVESTMENT MANAGEMENT LLC | 5.67% | 0.16% | 1,922,277 | 282,293 | 17.21% | 23,644,007,000 | Mar 31, 2023 |
MWG MANAGEMENT LTD. | 5.42% | 15.90% | 1,835,876 | - | - | 22,581,275,000 | Mar 31, 2023 |
FIL LTD | 5.33% | 0.03% | 1,805,558 | - | - | 22,208,363,000 | Mar 31, 2023 |
BLACKROCK INC. | 4.47% | 0.00% | 1,514,123 | 26,277 | 1.77% | 18,623,714,000 | Mar 31, 2023 |
BAKER BROS. ADVISORS LP | 3.03% | 0.07% | 1,028,466 | - | - | 12,650,132,000 | Mar 31, 2023 |
NIKKO ASSET MANAGEMENT AMERICAS, INC. | 2.95% | 0.13% | 999,333 | 511,107 | 104.69% | 10,992,663,000 | Mar 31, 2023 |
SUMITOMO MITSUI TRUST HOLDINGS, INC. | 2.94% | 0.01% | 997,572 | 509,346 | 104.33% | 12,270,136,000 | Mar 31, 2023 |
PRICE T ROWE ASSOCIATES INC /MD/ | 2.67% | 0.00% | 903,741 | -1,474,841 | -62.01% | 11,117,000 | Mar 31, 2023 |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2.61% | 0.24% | 885,314 | - | - | 10,889,362,000 | Mar 31, 2023 |
VANGUARD GROUP INC | 2.61% | 0.00% | 884,446 | 11,923 | 1.37% | 10,878,686,000 | Mar 31, 2023 |
CASDIN CAPITAL, LLC | 2.17% | 0.74% | 734,350 | - | - | 9,032,505,000 | Mar 31, 2023 |
CORMORANT ASSET MANAGEMENT, LP | 2.17% | 0.59% | 734,350 | - | - | 9,033,000 | Mar 31, 2023 |
ECOR1 CAPITAL, LLC | 1.77% | 0.24% | 600,000 | - | - | 7,380,000,000 | Mar 31, 2023 |
MOORE CAPITAL MANAGEMENT, LP | 1.48% | 0.13% | 500,000 | - | - | 6,150,000,000 | Mar 31, 2023 |
SAMSARA BIOCAPITAL, LLC | 1.39% | 1.19% | 470,304 | - | - | 5,784,739,000 | Mar 31, 2023 |
GREENWICH WEALTH MANAGEMENT LLC | 1.03% | 0.47% | 349,000 | 349,000 | 100.00% | 4,293,000 | Mar 31, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | 0.71% | 0.00% | 240,345 | 6,050 | 2.58% | 2,956,243,000 | Mar 31, 2023 |
Prime Medicine's largest institutional shareholder is ALPHABET INC., holding 39.20% of the company's total share outstanding, currently valued at $163.40B. The top 10 institutional shareholders own together 100.02% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
MWG MANAGEMENT LTD. | 5.42% | 15.90% | 1,835,876 | - | - | 22,581,275,000 | Mar 31, 2023 |
ALPHABET INC. | 39.20% | 9.06% | 13,284,688 | - | - | 163,401,662,000 | Mar 31, 2023 |
OUP MANAGEMENT CO., LLC | 0.36% | 2.98% | 121,255 | - | - | 1,491,437,000 | Mar 31, 2023 |
SAMSARA BIOCAPITAL, LLC | 1.39% | 1.19% | 470,304 | - | - | 5,784,739,000 | Mar 31, 2023 |
REDMILE GROUP, LLC | 5.88% | 1.06% | 1,992,843 | -216,507 | -9.80% | 24,511,969,000 | Mar 31, 2023 |
CASDIN CAPITAL, LLC | 2.17% | 0.74% | 734,350 | - | - | 9,032,505,000 | Mar 31, 2023 |
CORMORANT ASSET MANAGEMENT, LP | 2.17% | 0.59% | 734,350 | - | - | 9,033,000 | Mar 31, 2023 |
GREENWICH WEALTH MANAGEMENT LLC | 1.03% | 0.47% | 349,000 | 349,000 | 100.00% | 4,293,000 | Mar 31, 2023 |
WEXFORD CAPITAL LP | 0.45% | 0.39% | 153,705 | 153,705 | 100.00% | 1,890,572,000 | Mar 31, 2023 |
BRANDYWINE MANAGERS, LLC | 0.10% | 0.29% | 32,977 | - | - | 405,617,000 | Mar 31, 2023 |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2.61% | 0.24% | 885,314 | - | - | 10,889,362,000 | Mar 31, 2023 |
ECOR1 CAPITAL, LLC | 1.77% | 0.24% | 600,000 | - | - | 7,380,000,000 | Mar 31, 2023 |
ARK INVESTMENT MANAGEMENT LLC | 5.67% | 0.16% | 1,922,277 | 282,293 | 17.21% | 23,644,007,000 | Mar 31, 2023 |
MOORE CAPITAL MANAGEMENT, LP | 1.48% | 0.13% | 500,000 | - | - | 6,150,000,000 | Mar 31, 2023 |
NIKKO ASSET MANAGEMENT AMERICAS, INC. | 2.95% | 0.13% | 999,333 | 511,107 | 104.69% | 10,992,663,000 | Mar 31, 2023 |
RED LIGHTHOUSE INVESTMENT MANAGEMENT, LLC | 0.04% | 0.09% | 14,950 | 14,950 | 100.00% | 183,885,000 | Mar 31, 2023 |
BAKER BROS. ADVISORS LP | 3.03% | 0.07% | 1,028,466 | - | - | 12,650,132,000 | Mar 31, 2023 |
FIL LTD | 5.33% | 0.03% | 1,805,558 | - | - | 22,208,363,000 | Mar 31, 2023 |
SANDIA INVESTMENT MANAGEMENT LP | 0.03% | 0.02% | 10,000 | - | - | 123,000,000 | Mar 31, 2023 |
CLARIUS GROUP, LLC | 0.05% | 0.02% | 16,080 | - | - | 197,784,000 | Mar 31, 2023 |
The largest Prime Medicine shareholder by % of total assets is MWG MANAGEMENT LTD.. The company owns 1.84M shares of Prime Medicine (PRME), representing 15.90% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
NIKKO ASSET MANAGEMENT AMERICAS, INC. | 2.95% | 0.13% | 999,333 | 511,107 | 104.69% | 10,992,663,000 | Mar 31, 2023 |
SUMITOMO MITSUI TRUST HOLDINGS, INC. | 2.94% | 0.01% | 997,572 | 509,346 | 104.33% | 12,270,136,000 | Mar 31, 2023 |
GREENWICH WEALTH MANAGEMENT LLC | 1.03% | 0.47% | 349,000 | 349,000 | 100.00% | 4,293,000 | Mar 31, 2023 |
ARK INVESTMENT MANAGEMENT LLC | 5.67% | 0.16% | 1,922,277 | 282,293 | 17.21% | 23,644,007,000 | Mar 31, 2023 |
WEXFORD CAPITAL LP | 0.45% | 0.39% | 153,705 | 153,705 | 100.00% | 1,890,572,000 | Mar 31, 2023 |
BANK OF AMERICA CORP /DE/ | 0.44% | 0.00% | 150,267 | 102,908 | 217.29% | 1,848,284,000 | Mar 31, 2023 |
STATE STREET CORP | 0.56% | 0.00% | 189,428 | 74,582 | 64.94% | 2,329,964,000 | Mar 31, 2023 |
FMR LLC | 25.13% | 0.01% | 8,517,129 | 54,083 | 0.64% | 104,760,687,000 | Mar 31, 2023 |
SWISS NATIONAL BANK | 0.12% | 0.00% | 41,900 | 41,900 | 100.00% | 515,370,000 | Mar 31, 2023 |
JUMP FINANCIAL, LLC | 0.10% | 0.02% | 32,500 | 32,500 | 100.00% | 399,750,000 | Mar 31, 2023 |
PANAGORA ASSET MANAGEMENT INC | 0.10% | 0.00% | 32,197 | 32,197 | 100.00% | 396,023,000 | Mar 31, 2023 |
BLACKROCK INC. | 4.47% | 0.00% | 1,514,123 | 26,277 | 1.77% | 18,623,714,000 | Mar 31, 2023 |
CUBIST SYSTEMATIC STRATEGIES, LLC | 0.06% | 0.00% | 19,663 | 18,539 | 1649.38% | 241,855,000 | Mar 31, 2023 |
STATE OF WISCONSIN INVESTMENT BOARD | 0.05% | 0.00% | 17,999 | 17,999 | 100.00% | 221,388,000 | Mar 31, 2023 |
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 0.06% | 0.00% | 20,967 | 16,823 | 405.96% | 257,894,000 | Mar 31, 2023 |
RED LIGHTHOUSE INVESTMENT MANAGEMENT, LLC | 0.04% | 0.09% | 14,950 | 14,950 | 100.00% | 183,885,000 | Mar 31, 2023 |
CAPSTONE INVESTMENT ADVISORS, LLC | 0.04% | 0.00% | 14,551 | 14,551 | 100.00% | 178,977,000 | Mar 31, 2023 |
JANUS HENDERSON GROUP PLC | 0.04% | 0.00% | 14,091 | 14,091 | 100.00% | 173,111,000 | Mar 31, 2023 |
CREDIT SUISSE AG/ | 0.04% | 0.00% | 14,705 | 13,905 | 1738.13% | 180,872,000 | Mar 31, 2023 |
MORGAN STANLEY | 0.10% | - | 33,385 | 12,996 | 63.74% | 410,636,000 | Mar 31, 2023 |
As of Mar 31 2023, Prime Medicine's largest institutional buyer is NIKKO ASSET MANAGEMENT AMERICAS, INC.. The company purchased 511.11K stocks of PRME, valued at $10.99B.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
PRICE T ROWE ASSOCIATES INC /MD/ | 2.67% | 0.00% | 903,741 | -1,474,841 | -62.01% | 11,117,000 | Mar 31, 2023 |
REDMILE GROUP, LLC | 5.88% | 1.06% | 1,992,843 | -216,507 | -9.80% | 24,511,969,000 | Mar 31, 2023 |
CAAS CAPITAL MANAGEMENT LP | - | - | - | -89,331 | -100.00% | - | Mar 31, 2023 |
GHISALLO CAPITAL MANAGEMENT LLC | - | - | - | -70,000 | -100.00% | - | Mar 31, 2023 |
POINT72 MIDDLE EAST FZE | - | - | - | -37,609 | -100.00% | - | Mar 31, 2023 |
WALLEYE CAPITAL LLC | - | - | - | -30,000 | -100.00% | - | Mar 31, 2023 |
LMR PARTNERS LLP | - | - | - | -17,760 | -100.00% | - | Mar 31, 2023 |
LEVIN CAPITAL STRATEGIES, L.P. | - | - | - | -10,585 | -100.00% | - | Mar 31, 2023 |
ROYAL BANK OF CANADA | 0.00% | - | 590 | -957 | -61.86% | 7,000,000 | Mar 31, 2023 |
PENSERRA CAPITAL MANAGEMENT LLC | 0.02% | 0.00% | 7,000 | -570 | -7.53% | 86,000 | Mar 31, 2023 |
AMALGAMATED BANK | 0.00% | 0.00% | 1,264 | -303 | -19.34% | 16,000 | Mar 31, 2023 |
FIRST HORIZON ADVISORS, INC. | 0.01% | 0.00% | 1,698 | -115 | -6.34% | 20,885,000 | Mar 31, 2023 |
MWG MANAGEMENT LTD. | 5.42% | 15.90% | 1,835,876 | - | - | 22,581,275,000 | Mar 31, 2023 |
ALPHABET INC. | 39.20% | 9.06% | 13,284,688 | - | - | 163,401,662,000 | Mar 31, 2023 |
OUP MANAGEMENT CO., LLC | 0.36% | 2.98% | 121,255 | - | - | 1,491,437,000 | Mar 31, 2023 |
SAMSARA BIOCAPITAL, LLC | 1.39% | 1.19% | 470,304 | - | - | 5,784,739,000 | Mar 31, 2023 |
CASDIN CAPITAL, LLC | 2.17% | 0.74% | 734,350 | - | - | 9,032,505,000 | Mar 31, 2023 |
CORMORANT ASSET MANAGEMENT, LP | 2.17% | 0.59% | 734,350 | - | - | 9,033,000 | Mar 31, 2023 |
BRANDYWINE MANAGERS, LLC | 0.10% | 0.29% | 32,977 | - | - | 405,617,000 | Mar 31, 2023 |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2.61% | 0.24% | 885,314 | - | - | 10,889,362,000 | Mar 31, 2023 |
As of Mar 31 2023, Prime Medicine's biggest institutional seller is PRICE T ROWE ASSOCIATES INC /MD/. The company sold -1.47M shares of PRME, valued at $11.12M.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
GREENWICH WEALTH MANAGEMENT LLC | 1.03% | 0.47% | 349,000 | 349,000 | 100.00% | 4,293,000 | Mar 31, 2023 |
WEXFORD CAPITAL LP | 0.45% | 0.39% | 153,705 | 153,705 | 100.00% | 1,890,572,000 | Mar 31, 2023 |
SWISS NATIONAL BANK | 0.12% | 0.00% | 41,900 | 41,900 | 100.00% | 515,370,000 | Mar 31, 2023 |
JUMP FINANCIAL, LLC | 0.10% | 0.02% | 32,500 | 32,500 | 100.00% | 399,750,000 | Mar 31, 2023 |
PANAGORA ASSET MANAGEMENT INC | 0.10% | 0.00% | 32,197 | 32,197 | 100.00% | 396,023,000 | Mar 31, 2023 |
STATE OF WISCONSIN INVESTMENT BOARD | 0.05% | 0.00% | 17,999 | 17,999 | 100.00% | 221,388,000 | Mar 31, 2023 |
RED LIGHTHOUSE INVESTMENT MANAGEMENT, LLC | 0.04% | 0.09% | 14,950 | 14,950 | 100.00% | 183,885,000 | Mar 31, 2023 |
CAPSTONE INVESTMENT ADVISORS, LLC | 0.04% | 0.00% | 14,551 | 14,551 | 100.00% | 178,977,000 | Mar 31, 2023 |
JANUS HENDERSON GROUP PLC | 0.04% | 0.00% | 14,091 | 14,091 | 100.00% | 173,111,000 | Mar 31, 2023 |
MILLENNIUM MANAGEMENT LLC | 0.03% | 0.00% | 10,759 | 10,759 | 100.00% | 132,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 0.01% | - | 1,936 | 1,936 | 100.00% | 23,813,000 | Mar 31, 2023 |
LAZARD ASSET MANAGEMENT LLC | 0.00% | - | 1,521 | 1,521 | 100.00% | 18,000 | Mar 31, 2023 |
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 0.00% | - | 1,151 | 1,151 | 100.00% | 14,157,000 | Mar 31, 2023 |
TCI WEALTH ADVISORS, INC. | 0.00% | 0.00% | 231 | 231 | 100.00% | 2,842,000 | Mar 31, 2023 |
FEDERATED HERMES, INC. | 0.00% | - | 45 | 45 | 100.00% | 554,000 | Mar 31, 2023 |
Prime Medicine's largest new institutional shareholder by number of shares is GREENWICH WEALTH MANAGEMENT LLC, purchased 349.00K shares, valued at $4.29M, as of undefined.
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
CAAS CAPITAL MANAGEMENT LP | - | - | - | -89,331 | -100.00% | - | Mar 31, 2023 |
GHISALLO CAPITAL MANAGEMENT LLC | - | - | - | -70,000 | -100.00% | - | Mar 31, 2023 |
POINT72 MIDDLE EAST FZE | - | - | - | -37,609 | -100.00% | - | Mar 31, 2023 |
WALLEYE CAPITAL LLC | - | - | - | -30,000 | -100.00% | - | Mar 31, 2023 |
LMR PARTNERS LLP | - | - | - | -17,760 | -100.00% | - | Mar 31, 2023 |
LEVIN CAPITAL STRATEGIES, L.P. | - | - | - | -10,585 | -100.00% | - | Mar 31, 2023 |
Prime Medicine's largest sold out institutional shareholder by shares sold is CAAS CAPITAL MANAGEMENT LP, sold -89.33K shares, valued at -, as of undefined.
Prime Medicine Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
Kelly Strategic ETF Trust | 0.79% | 21,546 | - | - | Feb 29, 2024 |
Ark Venture Fund | 0.37% | 34,891 | 4,375 | 14.34% | Jan 31, 2024 |
T. Rowe Price New Horizons Fund, Inc. | 0.33% | 1,631,137 | 185,391 | 12.82% | Mar 31, 2024 |
Ark ETF Trust | 0.31% | 2,522,247 | -182,417 | -6.74% | Jan 31, 2024 |
T. Rowe Price Small-Cap Stock Fund, Inc. | 0.20% | 742,306 | 742,306 | - | Mar 31, 2024 |
BlackRock Health Sciences Trust II | 0.16% | 412,139 | - | - | Mar 31, 2024 |
T. Rowe Price Small-Cap Value Fund, Inc. | 0.10% | 801,678 | 801,678 | - | Mar 31, 2024 |
ROYCE MICRO-CAP TRUST, INC. | 0.10% | 46,214 | 6,377 | 16.01% | Mar 31, 2024 |
BlackRock Health Sciences Trust | 0.09% | 22,929 | - | - | Mar 31, 2024 |
T. Rowe Price Health Sciences Fund, Inc. | 0.08% | 276,452 | -24,554 | -8.16% | Mar 31, 2024 |
VANGUARD VALLEY FORGE FUNDS | 0.05% | 28,442 | - | - | Mar 31, 2024 |
T. Rowe Price Equity Funds, Inc. | 0.03% | 346,417 | 346,417 | - | Mar 31, 2024 |
Listed Funds Trust | 0.02% | 85,183 | 10,153 | 13.53% | Mar 31, 2024 |
T. Rowe Price Equity Series, Inc. | 0.01% | 23,421 | 9,166 | 64.30% | Mar 31, 2024 |
VANGUARD INDEX FUNDS | 0.01% | 5,305,442 | 1,039,962 | 24.38% | Mar 31, 2024 |
QUANTITATIVE MASTER SERIES LLC | 0.01% | 72,268 | - | - | Mar 31, 2024 |
DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 6,120 | - | - | Mar 31, 2024 |
TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 1,074 | - | - | Mar 31, 2024 |
SCHWAB CAPITAL TRUST | 0.00% | 110,228 | - | - | Jan 31, 2024 |
Investment Managers Series Trust II | 0.00% | 31,683 | -11,157 | -26.04% | Mar 31, 2024 |
VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 45,393 | 16,482 | 57.01% | Mar 31, 2024 |
Calvert Variable Products, Inc. | 0.00% | 3,901 | - | - | Mar 31, 2024 |
Principal Exchange-Traded Funds | 0.00% | 12,314 | -1,014 | -7.61% | Mar 31, 2024 |
FIDELITY SELECT PORTFOLIOS | 0.00% | 53,800 | - | - | Feb 29, 2024 |
BlackRock ETF Trust | 0.00% | 730 | 26 | 3.69% | Jan 31, 2024 |
Direxion Shares ETF Trust | 0.00% | 101,265 | - | - | Jan 31, 2024 |
Managed Portfolio Series | 0.00% | 13,774 | 13,774 | - | Mar 31, 2024 |
FIDELITY COVINGTON TRUST | 0.00% | 10,339 | - | - | Jan 31, 2024 |
Global X Funds | 0.00% | 18,871 | - | - | Jan 31, 2024 |
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,999 | - | - | Mar 31, 2024 |
Voya VARIABLE PORTFOLIOS INC | 0.00% | 12,906 | -3,254 | -20.14% | Mar 31, 2024 |
CLEARWATER INVESTMENT TRUST | 0.00% | 2,405 | 2,405 | - | Mar 28, 2024 |
TIAA-CREF LIFE FUNDS | 0.00% | 667 | - | - | Mar 31, 2024 |
STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 13,500 | - | - | Mar 31, 2024 |
T. Rowe Price Index Trust, Inc. | 0.00% | 2,541 | 180 | 7.62% | Mar 31, 2024 |
NORTHERN FUNDS | 0.00% | 16,045 | -474 | -2.87% | Mar 28, 2024 |
THRIVENT SERIES FUND INC | 0.00% | 11,216 | - | - | Mar 28, 2024 |
iSHARES TRUST | 0.00% | 1,681,313 | -55,799 | -3.21% | Mar 31, 2024 |
EQ ADVISORS TRUST | 0.00% | 116,051 | 2,800 | 2.47% | Mar 31, 2024 |
RYDEX SERIES FUNDS | 0.00% | 360 | - | - | Dec 31, 2023 |
HC CAPITAL TRUST | 0.00% | 2,301 | - | - | Mar 31, 2024 |
COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 61,859 | 42,280 | 215.95% | Mar 31, 2024 |
BLACKROCK FUNDS | 0.00% | 360,982 | - | - | Feb 29, 2024 |
PENN SERIES FUNDS INC | 0.00% | 1,500 | - | - | Mar 28, 2024 |
ALLSPRING MASTER TRUST | 0.00% | 3,067 | - | - | Feb 29, 2024 |
NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 5,948 | - | - | Mar 31, 2024 |
RYDEX DYNAMIC FUNDS | 0.00% | 179 | - | - | Dec 31, 2023 |
NATIONWIDE MUTUAL FUNDS | 0.00% | 4,075 | -618 | -13.17% | Jan 31, 2024 |
TIAA-CREF FUNDS | 0.00% | 85,602 | - | - | Jan 31, 2024 |
SPDR SERIES TRUST | 0.00% | 1,034,455 | - | - | Mar 31, 2024 |
ProFunds | 0.00% | 308 | -24 | -7.23% | Mar 31, 2024 |
AMERICAN CENTURY ETF TRUST | 0.00% | 2,472 | - | - | Feb 29, 2024 |
RYDEX VARIABLE TRUST | 0.00% | 24 | - | - | Dec 31, 2023 |
USAA MUTUAL FUNDS TRUST | 0.00% | 4,490 | 748 | 19.99% | Jan 31, 2024 |
JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 34,134 | 4,831 | 16.49% | Mar 31, 2024 |
Brighthouse Funds Trust II | 0.00% | 13,523 | - | - | Mar 31, 2024 |
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 33,200 | - | - | Mar 31, 2024 |
SUNAMERICA SERIES TRUST | 0.00% | 4,482 | -18 | -0.40% | Jan 31, 2024 |
J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 5,316 | - | - | Jan 31, 2024 |
PACIFIC SELECT FUND | 0.00% | 29,289 | -241 | -0.82% | Mar 31, 2024 |
Blackstone Alternative Investment Funds | 0.00% | 900 | 800 | 800.00% | Mar 31, 2024 |
Bridge Builder Trust | 0.00% | 29,758 | 176 | 0.59% | Mar 31, 2024 |
MASSMUTUAL SELECT FUNDS | 0.00% | 5,848 | 1,408 | 31.71% | Dec 31, 2023 |
FIDELITY SALEM STREET TRUST | 0.00% | 19,756 | 2,509 | 14.55% | Mar 31, 2024 |
ETF Series Solutions | 0.00% | 64 | - | - | Jan 31, 2024 |
BlackRock Variable Series Funds, Inc. | 0.00% | 4,866 | - | - | Mar 31, 2024 |
Advisors' Inner Circle Fund III | 0.00% | 102 | 33 | 47.83% | Jan 31, 2024 |
PRINCIPAL FUNDS, INC. | 0.00% | 4,961 | 1,051 | 26.88% | Jan 31, 2024 |
John Hancock Funds II | 0.00% | 11,330 | -3,111 | -21.54% | Feb 29, 2024 |
Prime Medicine's largest mutual fund holder by % of total assets is "Kelly Strategic ETF Trust", owning 21.55K shares, compromising 0.79% of its total assets.
Prime Medicine Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
31 Mar, 23 | 73 | 12.31% |
31 Dec, 22 | 65 | - |
30 Sep, 19 | - | -100.00% |
30 Jun, 19 | 4 | - |
31 Mar, 19 | 4 | -20.00% |
31 Dec, 18 | 5 | 25.00% |
30 Sep, 18 | 4 | 33.33% |
30 Jun, 18 | 3 | - |
31 Mar, 18 | 3 | 50.00% |
31 Dec, 17 | 2 | - |
30 Sep, 17 | 2 | -33.33% |
30 Jun, 17 | 3 | 50.00% |
31 Mar, 17 | 2 | -60.00% |
31 Dec, 16 | 5 | 25.00% |
30 Sep, 16 | 4 | - |
30 Jun, 16 | 4 | 33.33% |
31 Mar, 16 | 3 | 50.00% |
31 Dec, 15 | 2 | - |
As of 31 Mar 23, 73 institutions are holding Prime Medicine's shares, representing an increase of 12.31% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
31 Mar, 23 | 41,738,575 | 1.01% |
31 Dec, 22 | 41,322,385 | - |
30 Sep, 19 | - | -100.00% |
30 Jun, 19 | 53,032 | 25.62% |
31 Mar, 19 | 42,217 | 53.33% |
31 Dec, 18 | 27,533 | -47.50% |
30 Sep, 18 | 52,447 | 484.11% |
30 Jun, 18 | 8,979 | -54.07% |
31 Mar, 18 | 19,550 | 2191.91% |
31 Dec, 17 | 853 | -92.71% |
30 Sep, 17 | 11,697 | -15.94% |
30 Jun, 17 | 13,915 | -38.54% |
31 Mar, 17 | 22,640 | -66.62% |
31 Dec, 16 | 67,833 | 114.69% |
30 Sep, 16 | 31,596 | 9.49% |
30 Jun, 16 | 28,858 | 82.95% |
31 Mar, 16 | 15,774 | 21.15% |
31 Dec, 15 | 13,020 | - |
Prime Medicine (PRME) has 41.74M shares outstanding as of 31 Mar 23, up 1.01% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
31 Mar, 23 | 100.00% | - |
31 Dec, 22 | 100.00% | - |
30 Sep, 19 | - | - |
30 Jun, 19 | - | - |
31 Mar, 19 | - | - |
31 Dec, 18 | - | - |
30 Sep, 18 | - | - |
30 Jun, 18 | - | - |
31 Mar, 18 | - | - |
31 Dec, 17 | - | - |
30 Sep, 17 | - | - |
30 Jun, 17 | - | - |
31 Mar, 17 | - | - |
31 Dec, 16 | - | - |
30 Sep, 16 | - | - |
30 Jun, 16 | - | - |
31 Mar, 16 | - | - |
31 Dec, 15 | - | - |
As of 31 Mar 23, Prime Medicine is held by 100.00% institutional shareholders, representing a 0.00% growth compared to 31 Dec 22.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
31 Mar, 23 | 29 | - |
31 Dec, 22 | - | - |
30 Sep, 19 | - | -100.00% |
30 Jun, 19 | 2 | - |
31 Mar, 19 | - | -100.00% |
31 Dec, 18 | 2 | 100.00% |
30 Sep, 18 | 1 | - |
30 Jun, 18 | - | - |
31 Mar, 18 | - | - |
31 Dec, 17 | - | - |
30 Sep, 17 | - | -100.00% |
30 Jun, 17 | 1 | - |
31 Mar, 17 | 1 | - |
31 Dec, 16 | 1 | - |
30 Sep, 16 | - | - |
30 Jun, 16 | - | -100.00% |
31 Mar, 16 | 1 | - |
31 Dec, 15 | - | - |
29 institutional shareholders have increased their position in PRME stock as of 31 Mar 23 compared to - in the previous quarter (a 0.00% increase).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
31 Mar, 23 | 6 | - |
31 Dec, 22 | - | - |
30 Sep, 19 | - | - |
30 Jun, 19 | - | -100.00% |
31 Mar, 19 | 1 | - |
31 Dec, 18 | 1 | - |
30 Sep, 18 | - | - |
30 Jun, 18 | - | - |
31 Mar, 18 | - | - |
31 Dec, 17 | - | -100.00% |
30 Sep, 17 | 1 | - |
30 Jun, 17 | 1 | - |
31 Mar, 17 | - | - |
31 Dec, 16 | - | -100.00% |
30 Sep, 16 | 1 | - |
30 Jun, 16 | - | - |
31 Mar, 16 | - | - |
31 Dec, 15 | - | - |
6 institutional shareholders have reduced their position in PRME stock as of 31 Mar 23 compared to - in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
31 Mar, 23 | 73 | 12.31% | 41,738,575 | 1.01% | 100.00% | - | 29 | - | 6 | - |
31 Dec, 22 | 65 | - | 41,322,385 | - | 100.00% | - | - | - | - | - |
30 Sep, 19 | - | -100.00% | - | -100.00% | - | - | - | -100.00% | - | - |
30 Jun, 19 | 4 | - | 53,032 | 25.62% | - | - | 2 | - | - | -100.00% |
31 Mar, 19 | 4 | -20.00% | 42,217 | 53.33% | - | - | - | -100.00% | 1 | - |
31 Dec, 18 | 5 | 25.00% | 27,533 | -47.50% | - | - | 2 | 100.00% | 1 | - |
30 Sep, 18 | 4 | 33.33% | 52,447 | 484.11% | - | - | 1 | - | - | - |
30 Jun, 18 | 3 | - | 8,979 | -54.07% | - | - | - | - | - | - |
31 Mar, 18 | 3 | 50.00% | 19,550 | 2191.91% | - | - | - | - | - | - |
31 Dec, 17 | 2 | - | 853 | -92.71% | - | - | - | - | - | -100.00% |
30 Sep, 17 | 2 | -33.33% | 11,697 | -15.94% | - | - | - | -100.00% | 1 | - |
30 Jun, 17 | 3 | 50.00% | 13,915 | -38.54% | - | - | 1 | - | 1 | - |
31 Mar, 17 | 2 | -60.00% | 22,640 | -66.62% | - | - | 1 | - | - | - |
31 Dec, 16 | 5 | 25.00% | 67,833 | 114.69% | - | - | 1 | - | - | -100.00% |
30 Sep, 16 | 4 | - | 31,596 | 9.49% | - | - | - | - | 1 | - |
30 Jun, 16 | 4 | 33.33% | 28,858 | 82.95% | - | - | - | -100.00% | - | - |
31 Mar, 16 | 3 | 50.00% | 15,774 | 21.15% | - | - | 1 | - | - | - |
31 Dec, 15 | 2 | - | 13,020 | - | - | - | - | - | - | - |
Prime Medicine Insider Shareholders Trades
Open Market Insider Trades
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Open Market Insider Buys
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Insider Sells
All Insider Owners Trades
The last insider sell of Prime Medicine's stock was made by Gottesdiener Keith Michael on Jun 07 2024, selling 250,000 shares at - per share (valued at -).
Prime Medicine Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q2 2024 | 11 | 1 | 1100.00% |
Q1 2024 | 11 | - | - |
Q4 2023 | - | 2 | - |
Q3 2023 | - | 2 | - |
Q2 2023 | 9 | 55 | 16.36% |
Q1 2023 | 6 | - | - |
Q4 2022 | 19 | 21 | 90.48% |
11 total buy trades, and 1 total sell trades (buy/sell ratio of 11.00%) were made by Prime Medicine's insiders, as of Q2 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q2 2024 | - | - | - |
Q1 2024 | 3 | - | - |
Q4 2023 | - | - | - |
Q3 2023 | - | - | - |
Q2 2023 | - | 33 | - |
Q1 2023 | - | - | - |
Q4 2022 | 4 | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Prime Medicine's stocks.
Prime Medicine Peer Ownership
Ticker | Company |
---|---|
SANA | Sana Biotechnology, Inc. |
DNA | Ginkgo Bioworks Holdings, Inc. |
CRSP | CRISPR Therapeutics AG |
BPMC | Blueprint Medicines Corporation |
RPHM | Reneo Pharmaceuticals, Inc. |
IPSC | Century Therapeutics, Inc. |
NTLA | Intellia Therapeutics, Inc. |
EDIT | Editas Medicine, Inc. |
VERV | Verve Therapeutics, Inc. |
RLAY | Relay Therapeutics, Inc. |
CRBU | Caribou Biosciences, Inc. |
RPRX | Royalty Pharma plc |
OCEA | Ocean Biomedical, Inc. |
BEAM | Beam Therapeutics Inc. |
LIFE | aTyr Pharma, Inc. |
PRME Ownership FAQ
Who Owns Prime Medicine?
Prime Medicine is owned by institutional shareholders (100.00%), insiders (26.27%), and public (-26.27%). The largest institutional shareholder of Prime Medicine is ALPHABET INC. (39.20% of total shares) and the top mutual fund owner is Kelly Strategic ETF Trust (0.79% of total shares).
Who are the major institutional shareholders of Prime Medicine?
Prime Medicine's major institutional shareholders are ALPHABET INC., FMR LLC, REDMILE GROUP, LLC, ARK INVESTMENT MANAGEMENT LLC, and MWG MANAGEMENT LTD.. The top five shareholders own together 81.30% of the company's share outstanding.
How many Prime Medicine shareholders are there?
As of Mar 2023, there are 73 institutional shareholders of Prime Medicine.
What percentage of Prime Medicine is owned by ALPHABET INC?
ALPHABET INC owns 13.28M shares of Prime Medicine, representing 39.20% of the company's total shares outstanding, valued at $163.4B (as of Mar 2023).
What percentage of Prime Medicine is owned by FMR LLC?
As of Mar 2023, FMR LLC holds 8.52M shares of Prime Medicine (PRME), compromising 25.13% of the company, valued at $104.76B.
What percentage of Prime Medicine is owned by REDMILE GROUP, LLC?
REDMILE GROUP, LLC is the third largest holder of Prime Medicine. The company owns 1.99M of the company's shares outstanding (worth $24.51B).